LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,058,148 Value ($000) $134 Avg Close — Range —
Q4 2024
Shares 1,058,148 Value ($000) $218 Avg Close — Range —
Q3 2024
Shares 1,056,829 Value ($000) $272 Avg Close — Range —
Q2 2024
Shares 1,056,829 Value ($000) $292 Avg Close — Range —
Q1 2024
Shares 1,056,829 Value ($000) $6,573 Avg Close — Range —
Q4 2023
Shares 1,254,384 Value ($000) $6,573 Avg Close — Range —
Q3 2023
Shares 1,254,384 Value ($000) $4,905 Avg Close — Range —
Q2 2023
Shares 978,626 Value ($000) $4,022 Avg Close — Range —
Q1 2023
Shares 343,685 Value ($000) $711 Avg Close — Range —
Q4 2022
Shares 343,685 Value ($000) $1,079 Avg Close — Range —
Q3 2022
Shares 343,685 Value ($000) $1,722 Avg Close — Range —
Q2 2022
Shares 347,338 Value ($000) $1,963 Avg Close — Range —
Q1 2022
Shares 422,338 Value ($000) $1,698 Avg Close — Range —
Q4 2021
Shares 394,536 Value ($000) $1,719 Avg Close — Range —
Q3 2021
Shares 403,450 Value ($000) $3,688 Avg Close — Range —
Q2 2021
Shares 624,684 Value ($000) $5,017 Avg Close — Range —
Q1 2021
Shares 780,728 Value ($000) $9,048 Avg Close — Range —
Q4 2020
Shares 815,364 Value ($000) $9,295 Avg Close — Range —
Q3 2020
Shares 387,939 Value ($000) $4,338 Avg Close — Range —